Claire Blanchette is a Vice President, Compound Development Team Leader at Genmab where she is responsible for the leadership of an oncology asset team. Claire is passionate about bringing speed and efficiency to the the drug development process so effective treatments can reach patients around the world. Claire is PMP certified and previously held a variety of positions in clinical operations and development.